Tcf4 (BC014293) Mouse Tagged ORF Clone Lentiviral Particle
CAT#: MR208151L4V
- LentiORF®
-
Lenti ORF particles, Tcf4 (GFP-tagged) - Mouse transcription factor 4 (cDNA clone MGC:13998 IMAGE:4014231), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 11,115.00
货期*
详询
规格
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (3)
Specifications
Product Data | |
Product Name | Tcf4 (BC014293) Mouse Tagged ORF Clone Lentiviral Particle |
Synonyms | ME2, ITF-2, SEF-2, MITF-2A, MITF-2B, TFE, E2-2, E2.2, ITF2, SEF2, ASP-I2, ITF-2b, SEF2-1 |
Vector | pLenti-C-mGFP-P2A-Puro |
ACCN | BC014293 |
ORF Size | 1521 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(MR208151).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | BC014293, AAH14293 |
RefSeq Size | 1765 bp |
RefSeq ORF | 1523 bp |
Locus ID | 21413 |
Gene Summary | Transcription factor that binds to the immunoglobulin enhancer Mu-E5/KE5-motif. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3'). Isoform 2 inhibits MYOD1 activation of the cardiac alpha-actin promoter. Binds to the E-box present in the somatostatin receptor 2 initiator element (SSTR2-INR) to activate transcription. May have a regulatory function in developmental processes as well as during neuronal plasticity.[UniProtKB/Swiss-Prot Function] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...